Results 61 to 70 of about 48,911 (308)

Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis

Arthritis &Rheumatology, Accepted Article.
‐‐
Devis Benfaremo, Dinesh Khanna, Corrado Campochiaro, Vincent Cottin, Fabrizio Luppi, Marco Matucci‐Cerinic, Gianluca Moroncini, Yannick Allanore   +7 more
wiley   +1 more source

Inhaled Corticosteroids in COPD: Determinants of Use and Trends in Patient Persistance with Treatment

Canadian Respiratory Journal, 2004
METHODS: The determinants of a new treatment with inhaled corticosteroids and secular trends in patient persistence with treatment among chronic obstructive pulmonary disease (COPD) patients were investigated.
Lucie Blais, Jean Bourbeau, Odile Dheehy, Jacques LeLorier   +3 more
doaj   +1 more source

Current and potential improvements in the treatment of asthma from increased understanding of airway pathophysiology

Allergology International, 2002
The mainstay of chronic asthma management consists of using pharmacological agents that induce bronchodilatation, such as short-acting β-adrenergic receptor agonists (bronchodilators or relievers), and that control the chronic inflammatory process, such ...
Kian Fan Chung
doaj   +1 more source

Inhaled corticosteroids and growth - a review [PDF]

Jornal de Pediatria, 2000
OBJECTIVE: The aim of this review was to evaluate the medical literature in the last 10 years regarding the impact of the use of ICS on children and adolescents growth.METHODS: literature review.RESULTS: The use of ICS in childhood asthma in dosages appropriate to its severity does not seem to impair the adult height.CONCLUSIONS: The use of ICS in ...
E, Fortk, M, Brown
openaire   +2 more sources

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims This work assessed the pharmacokinetics (PK), safety and tolerability of glasmacinal (EP395, an oral anti‐inflammatory macrolide with negligible antimicrobial activity in development for COPD treatment) in two healthy participant trials: ‘first‐in‐human’ (FIH) and ‘drug–drug‐interaction’ (DDI).
Dave Singh, Kate Hanrott, Olof Breuer, Johan Bylund, Björn Schultze, Virginia Norris   +5 more
wiley   +1 more source

Improvement of Reduced Bone Mineral Density by Intermittent Cyclical Etidronate in Postmenopausal Asthmatic Patients Receiving Inhaled Corticosteroids

Allergology International, 2005
Background: We have recently shown that early postmenopausal but not premenopausal asthmatic women treated with inhaled corticosteroids demonstrate reduced bone mineral density(BMD)and decreased serum intact osteocalcin levels.
Hiroyasu Yamamoto, Soji Kasayama, Mari Fujita, Kimie Fujita, Yasuhiko Morimoto, Ichiro Kawase, Akihiko Miyatake   +6 more
doaj   +1 more source

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants

Children, 2021
Background: Very preterm birth often results in the development of bronchopulmonary dysplasia (BPD) with an inverse correlation of gestational age and birthweight.
Tobias Muehlbacher, Dirk Bassler, Manuel B. Bryant   +2 more
doaj   +1 more source

Withdrawal from treatment as an outcome in the Isolde study of COPD

, 2003
Objectives: To investigate the determinants of patient withdrawal from our study, and the effect of these withdrawals on the outcome of treatment with inhaled corticosteroids in patients with COPD.
Spencer, S, Spencer, Sally, Calverley, Peter MA, Jones, Paul W, Jones, PW, Willits, Lisa, Willits, L, Burge, P Sherwood, Spencer, Sally; id_orcid, Calverley, PMA, Burge, PS   +10 more
core   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Corticóide inalatório: efeitos no crescimento e na supressão adrenal Inhaled corticosteroids: effects on growth and adrenal suppression

Jornal Brasileiro de Pneumologia, 2005
Este artigo é uma revisão da literatura médica sobre os corticosteróides inalatórios e seus efeitos no crescimento e na supressão adrenal em crianças e adolescentes.
Elisete E. Arend, Gilberto Bueno Fischer, Helena Mocelin, Lídia Medeiros   +3 more
doaj   +1 more source